VIB Inks qBase+ Group Licensing Agreement with Biogazelle
News May 20, 2013
BITS, the bio-informatics training and service facility of the Belgian life sciences research institute VIB, has chosen qbase+ as the software to accelerate its qPCR analyses.
The qbase+ group license is available for more than ten VIB departments covering over 1000 researchers.
The director of BITS, Herwig Van Marck, cited: “qbase+ will allow us to improve the accuracy of our results and bring our qPCR based research to a higher level. The peer-reviewed software algorithms will help our researcher to annotate and process qPCR data according to international guidelines. To ensure the quality of the data we can rely on the various calculations available in qbase+ for post-PCR quality control, PCR efficiency correction, normalization, inter-run calibration, and statistics. This way, VIB researchers can efficiently analyze, interpret and visualize their data for various types of analysis: mRNA expression analysis, copy number analysis, miRNA profiling, ChIP-qPCR, and many others.”
While the practical performance of a real-time PCR quantification experiment is relatively straightforward, it is clear that many users experience a genuine need for more in depth training of their data-analysis skills.
To accommodate this need, Biogazelle has organized several training sessions for key qPCR users within VIB.
Within the framework of the collaboration, VIB can also rely on expert advice from Biogazelle.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
New Algorithms Help Extract 3-D Biological Structure from Limited DataNews
CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018